ARKG or IHI or VHT

Key Takeaways

• ARKG is an actively managed thematic ETF focused on the genomics revolution with high concentration and an expense ratio of 0.75%, while IHI and VHT are passively managed index trackers with lower costs.
• IHI provides targeted exposure to approximately 50 U.S. medical device companies through a sector-specific index, offering narrower but specialized healthcare positioning compared to the broad coverage of VHT.
• VHT delivers diversified access to the entire U.S. healthcare sector via hundreds of holdings across pharmaceuticals, biotechnology, devices, and services, with the lowest expense ratio at 0.09%.
• Structural differences drive risk profiles: ARKG features active stock selection and thematic concentration, IHI emphasizes medical equipment innovation, and VHT prioritizes broad sector representation for reduced single-stock risk.
• Expense ratios vary significantly, with VHT offering the greatest cost efficiency for long-term holding, followed by IHI, while ARKG’s higher fee reflects its active management approach.
• All three ETFs compete within healthcare but represent distinct strategies—active thematic, passive sector niche, and passive broad sector—allowing investors to match exposure to specific risk tolerances and objectives.

Introduction

These three ETFs are relevant to compare because they offer distinct approaches to healthcare sector exposure. ARKG employs active management with a thematic focus on genomics, whereas IHI and VHT are passive vehicles tracking indexes in medical devices and the broader health care sector, respectively. Investors evaluating thematic innovation versus broad diversification or specialized equipment exposure can use this comparison to assess structural differences, cost structures, and positioning within the evolving healthcare landscape.

ARK Genomic Revolution ETF (ARKG) Overview

The ARK Genomic Revolution ETF (ARKG) is an actively managed exchange-traded fund that seeks long-term growth of capital by investing in companies involved in the genomics revolution, including gene editing, sequencing, and related technologies. It does not track a traditional index and typically holds 30 to 40 securities with significant concentration in the top holdings. The portfolio emphasizes healthcare and biotechnology companies, with allocations also extending to information technology and materials where relevant to the theme. The expense ratio is 0.75%. Distinguishing features include ARK Invest’s discretionary stock selection and thematic rebalancing approach, which allows flexibility beyond rigid index rules but introduces higher concentration risk.

iShares U.S. Medical Devices ETF (IHI) Overview

The iShares U.S. Medical Devices ETF (IHI) is a passively managed fund that seeks to track the investment results of the Dow Jones U.S. Select Medical Equipment Index. This index measures the performance of U.S. equities primarily engaged in manufacturing and distributing medical devices and equipment. The ETF holds approximately 50 securities, providing focused exposure to this subsector. Sector allocation is concentrated in healthcare, specifically medical devices. The expense ratio is 0.40%. Key characteristics include quarterly index rebalancing, market-capitalization weighting, and a non-diversified structure that amplifies sensitivity to device industry dynamics such as regulatory approvals and technological advancements.

Vanguard Health Care ETF (VHT) Overview

The Vanguard Health Care ETF (VHT) is a passively managed fund designed to track the performance of the MSCI US Investable Market Health Care 25/50 Index. This benchmark includes large-, mid-, and small-cap U.S. stocks across the full healthcare sector, encompassing pharmaceuticals, biotechnology, medical devices, healthcare services, and equipment. VHT typically holds several hundred securities for broad diversification. Sector allocation remains entirely within healthcare. The expense ratio is 0.09%. Distinguishing features include full replication where possible, low turnover, and a 25/50 concentration cap to enhance diversification within the sector.

Industry and Thematic Landscape

The healthcare sector encompasses innovation in genomics, medical devices, pharmaceuticals, and services, driven by aging populations, chronic disease prevalence, technological advancements such as gene editing and diagnostics, and evolving regulatory frameworks. Capital flows into healthcare often reflect demographic tailwinds and research-and-development pipelines, while risks include policy changes, reimbursement pressures, and geopolitical supply-chain considerations. Earnings trends among major holdings tend to correlate with clinical trial outcomes, FDA approvals, and macroeconomic factors influencing healthcare spending. These external drivers affect all three ETFs but manifest differently based on each fund’s specific exposure profile.

Performance and Positioning Comparison

In recent market cycles, performance differences have stemmed primarily from structural variations. ARKG’s active thematic approach and higher concentration have contributed to greater volatility and sensitivity to genomics-specific news flow. IHI’s focused medical devices exposure has shown distinct behavior tied to equipment demand and innovation cycles, often exhibiting moderate volatility relative to broader markets. VHT’s broad diversification across healthcare subsectors has generally supported more stable trend consistency and lower drawdowns during sector rotations. Relative positioning reflects these design choices, with concentration risk highest in ARKG and lowest in VHT, while macro factor sensitivity varies according to subsector tilts.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening.

Tickeron AI Verdict

Based on observable structural strength, VHT demonstrates superior diversification depth, lowest expense ratio, and broad sector representation that supports more stable risk-adjusted positioning across market environments. IHI offers efficient targeted exposure within devices but with narrower scope, while ARKG’s active thematic strategy provides unique genomics access at higher cost and concentration. On balance, the AI would currently favor VHT for its cost efficiency and diversified profile within the healthcare theme.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations